ADI releases World Alzheimer Report 2010

The World Alzheimer Report 2010 was released today to mark World Alzheimer's Day and heighten awareness of the global economic impact of Alzheimer's disease and related dementias. 

Released by Alzheimer's Disease International (ADI), the Report paints a comprehensive picture of the ballooning personal, economic and social costs of dementia on world economies and draws a stark conclusion: Alzheimer's disease and related dementias are poised to be the single most significant health and social crisis of the 21st century.

"This is the second wake-up call for Canada," says Debbie Benczkowski, CEO of the Alzheimer Society. "World governments, including Canada, are woefully unprepared for the impending crisis unless we start acting now."

The World Alzheimer Report 2010 comes on the heels of the Society's own report, Rising Tide: The Impact of Dementia on Canadian Society, that was released last January.

"Today's release validates the findings of our Canadian study and is in line with recommendations we presented to the Federal Health Minister last January for a comprehensive National Dementia Strategy," explains Scott Dudgeon, Rising Tide's lead author. "We know from history that major diseases can be managed, even prevented, but this requires the political will to make greater investments in research and care options."

The Report also comes at a time when Canada and the Alzheimer Society prepare to host the 26th International Conference of Alzheimer's Disease International in Toronto in March.

"Canada does not currently have a National Dementia Strategy," adds Benczkowski. "This is an opportune time for all levels of Government to step up to the plate and position Canada as a world leader in dementia care and research. The Alzheimer Society is eager to work with the Federal Government and its Provincial and Territorial counterparts to make sure this happens."

World Alzheimer Report key findings:

  • Worldwide costs of dementia will exceed 1% of global GDP in 2010 - at US$604 billion. About 70% of the costs occur in Western Europe and North America.
  • If dementia care were a country, it would be the world's 18th largest economy.  If it were a company, it would be the world's largest by annual revenue exceeding Wal-Mart (US$414 billion) and Exxon Mobil (US$311 billion).
  • The number of people with dementia will double by 2030, and more than triple by 2050
  • The costs of caring for people with dementia will rise faster than the prevalence. Costs of informal care and the direct costs of social care generally contribute similar proportions of total costs, while the direct medical costs are much lower.
  • Countries like the UK report Alzheimer's disease as one of the costliest illnesses, yet research and investment are at a significantly lower level compared to other major illnesses. 

Recommended actions:

The World Alzheimer Report urges the global community to take the following immediate actions: 

  • World governments must act urgently to make Alzheimer's a top priority and develop national plans to tackle its social and health consequences.  Several countries have already moved in this direction, including France, Australia and England.
  • Governments and other major research funders must increase research funding to a level more proportionate to the economic burden of the disease. Recent UK data suggests that a 15-fold increase is required to reach parity with research into heart disease, and a 30-fold increase to achieve parity with cancer research.
  • Global governments must develop policies and plans for long-term care that anticipate and address social and demographic trends; these plans should focus on the needs of family caregivers and provide social protection for the most vulnerably affected.
  • The scale of the disease requires worldwide actions. It must be addressed as a top World Health Organization (WHO) priority and find its way onto the G-20 and G-8 Agendas.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common cardiovascular drugs linked to lower risk of dementia